Last $0.52 USD
Change Today +0.02 / 4.00%
Volume 225.0
ORGS On Other Exchanges
Symbol
Exchange
OTC US
As of 5:20 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

orgenesis inc (ORGS) Snapshot

Open
$0.52
Previous Close
$0.50
Day High
$0.52
Day Low
$0.52
52 Week High
07/30/13 - $0.81
52 Week Low
06/24/14 - $0.34
Market Cap
28.5M
Average Volume 10 Days
2.3K
EPS TTM
--
Shares Outstanding
54.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ORGENESIS INC (ORGS)

Related News

No related news articles were found.

orgenesis inc (ORGS) Related Businessweek News

No Related Businessweek News Found

orgenesis inc (ORGS) Details

Orgenesis Inc., a development stage company, is engaged in research and development in the biotechnology field in Israel. It intends to develop a technology for regeneration of functional insulin-producing cells thus enabling normal glucose regulated insulin secretion through cell therapy. The company was formerly known as Business Outsourcing Services, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was founded in 2008 and is based in White Plains, New York.

2 Employees
Last Reported Date: 05/30/14
Founded in 2008

orgenesis inc (ORGS) Top Compensated Officers

Founder and Chief Scientific Officer
Total Annual Compensation: $200.6K
Chief Executive Officer of Orgenesis Ltd and ...
Total Annual Compensation: $204.9K
Consultant
Total Annual Compensation: $126.6K
Compensation as of Fiscal Year 2013.

orgenesis inc (ORGS) Key Developments

Orgenesis Inc. Announces the Executive Changes

Effective April 16, 2014, Orgenesis Inc. announced that Dov Weinberg resigned as the Chief Financial Officer, Treasurer and Secretary. Mr. Weinberg’s resignation was not as a result of any disagreement with the company operations, policies or practices. Mr. Weinberg will remain as a consultant to the company. On April 16, 2014, the company appointed Joseph Tenne as the Chief Financial Officer, treasurer and Secretary pursuant to an employment agreement with the subsidiary, Orgenesis Ltd. Mr. Tenne is a Certified Public Accountant (Israel) with the Israeli Auditors' Council. He has over 20 years of managerial experience in public and private companies. From 2013 to present, Mr. Tenne has acted as an independent financial consultant.

Orgenesis Inc. Auditor Raises 'Going Concern' Doubt

Orgenesis Inc. filed its 10-K on Feb 19, 2014 for the period ending Nov 30, 2013. In this report its auditor, Kesselman & Kesselman, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Orgenesis Inc. Announces Executive Changes

Effective December 23, 2013, Orgenesis Inc. announced that Sav DiPasquale resigned as President and Chief Executive Officer of the company. On the same date, the company appointed Vered Caplan as interim President and Chief Executive Officer of the company until a replacement is named. Ms. Caplan currently serves as non-executive chairman of the Board of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ORGS:US $0.52 USD +0.02

ORGS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ORGS.
View Industry Companies
 

Industry Analysis

ORGS

Industry Average

Valuation ORGS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORGENESIS INC, please visit www.orgenesis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.